"NVIDIA Healthcare has launched generative AI microservices for drug discovery, MedTech, and digital health. These offerings, which include optimized AI models and workflows, can be used to create cloud-native applications and provide capabilities in imaging, natural language processing, and simulation. Companies like Amgen and DNA Nexus are already using these microservices. Additionally, NVIDIA has released NIM, which offers optimized inference for healthcare applications. Other companies such as Cadence, Hippocratic AI, Abridge, and Flywheel are also leveraging NVIDIA's generative AI microservices for various healthcare purposes. NVIDIA's AI Enterprise 5.0 allows developers to experiment and deploy these microservices. NVIDIA is a leading provider of data-center-scale computing infrastructure and is focused on driving industrial digitalization with AI technology."